Comprehensive Clinical Development Finalizes Acquisition of Charles River Clinical Services

Published on: 

Company News Release

Comprehensive Clinical Development, formerly operating as Comprehensive NeuroScience, Inc., announced today the acquisition of Charles River Clinical Services Northwest, Inc., including its 250-bed, 77,000-square-foot, Phase I-IIa facility located in Tacoma, Washington.

The increased capacity and capabilities deliver numerous benefits to support clients’ complete drug development programs, including:

Advertisement

  • Geographic diversification allowing clients a more proximal location to conduct studies and increase service offerings from coast to coast

  • Established experience in conducting radiolabeled studies

  • Streamlined optimization and extensive expertise in biologics studies

  • Access to leading physicians in numerous specialties including oncology, expansive patient populations and unique nuclear pharmacy capabilities, allowing for highly differentiated studies

  • Specialized pharmacy services optimized for compounding, including radiolabeled compounds

  • Extensive access to populations for targeting treatments for patients with Hepatitis C